Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Trelagliptin

A DPP-4 inhibitor (gliptin) for type 2 diabetes that boosts incretin hormones to help control blood sugar: it was approved in Japan in March 2015 and later also in India. This family brings together the active ingredient, labelled standards and other impurities.

Did you know?Chemically it is a fluorinated derivative of alogliptin, another gliptin: compared with similar gliptins, however, it has a much longer duration of action.

TrelagliptinGo to the active ingredient →
TrelagliptinActive ingredientTrelagliptinCat. No. P-T183-001CAS 865759-25-7

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.